GLOBAL PHARMATECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.15 USD | -37.50% |
|
-.--% | -37.50% |
| 3 months | -37.50% | ||
| 6 months | +25.00% |
| Sales 2006 | 2.38M 190M | Sales 2007 | 2.82M 226M | Capitalization | 13.95M 1.12B |
|---|---|---|---|---|---|
| Net income 2006 | -1M -80.05M | Net income 2007 | -3M -240M | EV / Sales 2006 | 11.5 x |
| Net cash position 2006 | 2.68 214.42 | Net cash position 2007 | 2.68 214.63 | EV / Sales 2007 | 4.95 x |
| P/E ratio 2006 |
-20.5
x | P/E ratio 2007 |
-4.23
x | Employees | 217 |
| Yield 2006 * |
-
| Yield 2007 |
-
| Free-Float | 16.09% |
More Fundamentals
* Assessed data
| 1 day | -37.50% | ||
| 3 months | -37.50% | ||
| 6 months | +25.00% | ||
| Current year | -37.50% |
Current year
0.15
0.15
1 year
0.110.25
3 years
0.100.60
5 years
0.010.60
10 years
0.010.90
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Sheng
BRD | Director/Board Member | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yong Sheng
BRD | Director/Board Member | - | - |
Global Pharmatech, Inc., formerly Global Pharmatech Pvt. Ltd., is a contract manufacturer of liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles The Company has manufactured products in various therapeutic segments such as Vitamin Supplements, Anaesthetics, Corticosteroids, Anti-emetics, Steroids with antibiotics, Anemia, Analgesics, Antihistamines, Anti Filarial. Its first product, Iron Sucrose, is being marketed in India. It offers the products for domestic as well as international market. Its products include Iron Sucrose Injection USP, Ondansetron Injection USP, Promethazine Injection BP, Tramadol HCI Injection, Metoclopramide Injection BP, Levetiracetam Injection and Amikacin Injection. The Company registers products in various markets around the world.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -37.50% | 59.28M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- GBLP Stock
